Melinta Therapeutics (CEMP) Annual Balance Sheets

Annual · GAAP · USD millions
Access CEMP quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Melinta Therapeutics's financial structure and capital allocation.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2018)
(Dec 31 2017) (Dec 31 2016) (Dec 31 2015) (Dec 31 2014)
Assets
Cash & cash equivalent81.81
Cash & Short-term Investments81.00
Accounts receivable22.49
Inventories41.34
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.85
Total Current Assets149.48
Equipment/Property/Plant Net1.59
Intangible Assets229.20
Deposits Assets, Noncurrent AS0.00
Other Assets, Noncurrent61.33
Total Assets441.59
Liabilities
Accounts Payable, Current AC16.77
Accrued Liabilities, Current33.92
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current82.92
Total Current Liabilities133.61
Long-term debt110.48
Total Long-term Debt110.48
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent7.44
Total Liabilities251.53
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock909.90
Retained Earnings / Accumulated Deficit-719.84
Other Equity0.00
Common Stockholder's Equity190.06
Total Stockholder's Equity190.06
Liabilities & Stockholder's Equity441.59
4 historic quarters locked

Sign in to unlock the full Melinta Therapeutics balance sheet history.

About CEMP Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.